Henry O. Gosebruch
Former President and Chief Executive OfficeratNeumora Therapeutics· In proxies 2023–2025
Pay in FY2025-72% from the year before · Neumora Therapeutics stock -83.1% the same year
Henry O. Gosebruch was paid $1.3M in FY2025 (Dec), down 72%. Neumora Therapeutics stock fell 83.1% that year.
Pay$100 in the stock at the end of FY23 → $10
Experience
- Neumora TherapeuticsPublic company · 3 yr
- Former President and Chief Executive Officer2023 – Present · 3 yrStock in role -98%
- AcelyrinPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- AptinyxPublic company · 4 yr
- Director2019 – 2023 · 4 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?